Session 13
Co-Infektionen

Programm

• 16:30 – 16:45 12 Min. 3 Min.

  • Abstract lecture
  • S13-01

  Posaconazole for Prevention of COVID-19 Associated Pulmonary Aspergillosis in Critically Ill patients: a prospective case-control study

  • Jürgen Prattes (Graz / AT)

   Clinical mycology, Therapy & resistance
• 16:45 – 17:00 12 Min. 3 Min.

  • Abstract lecture
  • S13-02

  Mycobiome Dynamics in Cystic Fibrosis: Impact of Antibiotics on Short-term and Cumulative Treatment

  FungiNet A5

  • Prof. Dr. Hortense Slevogt (Hannover / DE)

   Clinical mycology, Therapy & resistance
• 17:00 – 17:15 12 Min. 3 Min.

  • Abstract lecture
  • S13-03

  Strategies to treat vulvovaginal candidiasis: neutralizing candidalysin and augmenting the protective potential of probiotic lactobacilli to reduce Candida albicans pathogenicity

  • Marisa Valentine (Jena / DE)
• 17:15 – 17:30 12 Min. 3 Min.

  • Abstract lecture
  • S13-04

  The effect of lung colonisation with Candida albicans on Staphylococcus aureus infection

  • Tobias Köhler (Würzburg / DE)